Poly Medicure (531768) Q4 04/05 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 04/05 earnings summary
2 Nov, 2026Executive summary
FY2004-05 production reached a record 91.56 million medical disposables; net sales were Rs. 6,449.29 lakh and net profit was Rs. 608.30 lakh.
Products were exported to more than 40 countries; exports accounted for 86.4% of sales, up from 83.8% in FY2003-04.
Financial highlights
Net sales rose 31.2% YoY to Rs. 6,449.29 lakh from Rs. 4,914.13 lakh; other income was Rs. 54.45 lakh.
Operating profit was Rs. 1,192.38 lakh vs. Rs. 903.75 lakh; PBT rose 23.8% to Rs. 765 lakh from Rs. 618.25 lakh.
PAT increased 40.4% to Rs. 608.30 lakh from Rs. 433.33 lakh; EPS was Rs. 11.42 vs. Rs. 8.17.
Interest and finance charges were Rs. 162.24 lakh vs. Rs. 113 lakh; depreciation was Rs. 265.14 lakh vs. Rs. 172.50 lakh.
Outlook and guidance
FY2005-06 was expected to benefit from expanded production capacity; outlook was described as reasonably bright, subject to competition, currency moves and economic conditions.
A further expansion was underway and expected to finish by mid-FY2005-06 at a projected cost of Rs. 14.50 crore.
Latest events from Poly Medicure
- Acquisition-led revenue growth and a European rebound faced pressure on consolidated margins.531768
Q2 26/27 - Commercial production began in Apr 1997 after delays; FY turnover and PBT were nil.531768
Q4 96/97 - Revenue and production grew, but depreciation drove a FY99 net loss.531768
Q4 98/99 - First-period profit was modest as depressed markets and blood-bag restrictions curtailed performance.531768
Q4 97/98 - Profit returned as production grew 77.10% and export turnover nearly doubled.531768
Q4 99/00 - Higher production lifted profit, while commissioned expansion set up the next growth phase.531768
Q4 01/02 - FY04 growth and capacity expansion advanced, with exports at 83.8% of sales.531768
Q4 03/04 - Profit and exports surged as capacity expansion and Egypt production plans advanced.531768
Q4 02/03 - Record production and higher profit fuel expansion amid pricing and currency pressures.531768
Q4 05/06